P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction The PRIVATE-ATLANTIC study

P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC study. Publié dans Thrombosis and Haemostasis, le 19 mai 2015. En savoir plus en consultant le site de la revue. Auteurs : Silvain J, Storey RF, Cayla G, Esteve JB, Dillinger JG, Rousseau H, Tsatsaris A, Baradat…

Optimal timing of initiation of oral P2Y12-receptor antagonist therapy in patients with non-ST elevation acute coronary syndromes. Lessons learnt from the ACCOAST-trial.

Optimal timing of initiation of oral P2Y12-receptor antagonist therapy in patients with non-ST elevation acute coronary syndromes. Lessons learnt from the ACCOAST-trial. Publié dans European  Heart Journal : Acute Cardiovascular Care, le 28 avril 2015. En savoir plus en consultant le site. Auteurs : Zeymer U, Montalescot G, Ardissino D, Bolognese L, Clemmensen P, Collet JP, Lopez-Sendon…

Reply: Not All NSTEMIs Are Created Equal.

Reply: Not All NSTEMIs Are Created Equal. Publié dans Journal of the American College of Cardiology, le 28 avril 2015. En savoir plus en consultant le site. Auteurs : Montalescot G, Collet JP, Ecollan P, Bolognese L, ten Berg J, Dudek D, Hamm C, Widimsky P, Tanguay JF, Goldstein P, Brown E, Miller DL, LeNarz L, Vicaut…